ICD-10-PCS FY2024 code changes

ICD-10-PCS update effective October 1, 2023: 78 new codes, 5 deleted, 14 revised titles. Compared with FY2023 (April 1, 2023). CMS replaced the October 2023 order file with the April 1, 2024 one. Rebuilt by reversing the official April 1, 2024 order addenda.

Other ICD-10-PCS releases: FY2027, FY2026 (April 1, 2026), FY2026, FY2025 (April 1, 2025), FY2025, FY2024 (April 1, 2024), FY2023 (April 1, 2023), FY2023, FY2022 (April 1, 2022), FY2022, FY2021 (January 1, 2021), FY2021, FY2020 (August 1, 2020), FY2020, FY2019, FY2018, FY2017.

Also in this release: ICD-10-CM changes.

New codes (78)

• 02HW3RZ Insertion of Short-term External Heart Assist System into Thoracic Aorta, Descending, Percutaneous Approach
• 02PW3RZ Removal of Short-term External Heart Assist System from Thoracic Aorta, Descending, Percutaneous Approach
• 02WW3RZ Revision of Short-term External Heart Assist System in Thoracic Aorta, Descending, Percutaneous Approach
• 0CSS0ZZ Reposition Larynx, Open Approach
• 0CSS7ZZ Reposition Larynx, Via Natural or Artificial Opening
• 0CSS8ZZ Reposition Larynx, Via Natural or Artificial Opening Endoscopic
• 0DH17JZ Insertion of Magnetic Lengthening Device into Upper Esophagus, Via Natural or Artificial Opening
• 0DH27JZ Insertion of Magnetic Lengthening Device into Middle Esophagus, Via Natural or Artificial Opening
• 0DH37JZ Insertion of Magnetic Lengthening Device into Lower Esophagus, Via Natural or Artificial Opening
• 0WHC0GZ Insertion of Defibrillator Lead into Mediastinum, Open Approach
• 0WHC3GZ Insertion of Defibrillator Lead into Mediastinum, Percutaneous Approach
• 0WHC4GZ Insertion of Defibrillator Lead into Mediastinum, Percutaneous Endoscopic Approach
• 0WPC0GZ Removal of Defibrillator Lead from Mediastinum, Open Approach
• 0WPC3GZ Removal of Defibrillator Lead from Mediastinum, Percutaneous Approach
• 0WPC4GZ Removal of Defibrillator Lead from Mediastinum, Percutaneous Endoscopic Approach
• 0WPCXGZ Removal of Defibrillator Lead from Mediastinum, External Approach
• 0WWC0GZ Revision of Defibrillator Lead in Mediastinum, Open Approach
• 0WWC3GZ Revision of Defibrillator Lead in Mediastinum, Percutaneous Approach
• 0WWC4GZ Revision of Defibrillator Lead in Mediastinum, Percutaneous Endoscopic Approach
• 0WWCXGZ Revision of Defibrillator Lead in Mediastinum, External Approach
• 5A09B5K Assistance with Respiratory Ventilation, Less than 8 Consecutive Hours, Intubated Prone Positioning
• 5A09C5K Assistance with Respiratory Ventilation, 8-24 Consecutive Hours, Intubated Prone Positioning
• 5A09D5K Assistance with Respiratory Ventilation, Greater than 24 Consecutive Hours, Intubated Prone Positioning
• 8E0U0EN Fluorescence Guided Procedure of Female Reproductive System using Pafolacianine, Open Approach
• 8E0U3EN Fluorescence Guided Procedure of Female Reproductive System using Pafolacianine, Percutaneous Approach
• 8E0U4EN Fluorescence Guided Procedure of Female Reproductive System using Pafolacianine, Percutaneous Endoscopic Approach
• 8E0U7EN Fluorescence Guided Procedure of Female Reproductive System using Pafolacianine, Via Natural or Artificial Opening
• 8E0U8EN Fluorescence Guided Procedure of Female Reproductive System using Pafolacianine, Via Natural or Artificial Opening Endoscopic
• 8E0W0EN Fluorescence Guided Procedure of Trunk Region using Pafolacianine, Open Approach
• 8E0W3EN Fluorescence Guided Procedure of Trunk Region using Pafolacianine, Percutaneous Approach
• 8E0W4EN Fluorescence Guided Procedure of Trunk Region using Pafolacianine, Percutaneous Endoscopic Approach
• 8E0W7EN Fluorescence Guided Procedure of Trunk Region using Pafolacianine, Via Natural or Artificial Opening
• 8E0W8EN Fluorescence Guided Procedure of Trunk Region using Pafolacianine, Via Natural or Artificial Opening Endoscopic
• X051329 Destruction of Renal Sympathetic Nerve(s) using Ultrasound Ablation, Percutaneous Approach, New Technology Group 9
• X2H03R9 Insertion of Intraluminal Device, Bioprosthetic Valve into Inferior Vena Cava, Percutaneous Approach, New Technology Group 9
• X2H13R9 Insertion of Intraluminal Device, Bioprosthetic Valve into Superior Vena Cava, Percutaneous Approach, New Technology Group 9
• X2H20R9 Insertion of Intraluminal Device, Bioprosthetic Valve into Right Femoral Vein, Open Approach, New Technology Group 9
• X2H30R9 Insertion of Intraluminal Device, Bioprosthetic Valve into Left Femoral Vein, Open Approach, New Technology Group 9
• X2H63V9 Insertion of Dual-Chamber Intracardiac Pacemaker into Right Atrium, Percutaneous Approach, New Technology Group 9
• X2HK3V9 Insertion of Dual-Chamber Intracardiac Pacemaker into Right Ventricle, Percutaneous Approach, New Technology Group 9
• X2HL0F9 Insertion of Conduit to Short-term External Heart Assist System into Right Axillary Artery, Open Approach, New Technology Group 9
• X2HM0F9 Insertion of Conduit to Short-term External Heart Assist System into Left Axillary Artery, Open Approach, New Technology Group 9
• X2HX0F9 Insertion of Conduit to Short-term External Heart Assist System into Thoracic Aorta, Ascending, Open Approach, New Technology Group 9
• X2KH3D9 Bypass Right Femoral Artery using Conduit through Femoral Vein to Superficial Femoral Artery, Percutaneous Approach, New Technology Group 9
• X2KH3E9 Bypass Right Femoral Artery using Conduit through Femoral Vein to Popliteal Artery, Percutaneous Approach, New Technology Group 9
• X2KJ3D9 Bypass Left Femoral Artery using Conduit through Femoral Vein to Superficial Femoral Artery, Percutaneous Approach, New Technology Group 9
• X2KJ3E9 Bypass Left Femoral Artery using Conduit through Femoral Vein to Popliteal Artery, Percutaneous Approach, New Technology Group 9
• X2U4079 Supplement Coronary Artery/Arteries with Vein Graft Extraluminal Support Device(s), Open Approach, New Technology Group 9
• X2UQ0P9 Supplement Right Upper Extremity Vein with Synthetic Substitute, Extraluminal Support Device, Open Approach, New Technology Group 9
• X2UR0P9 Supplement Left Upper Extremity Vein with Synthetic Substitute, Extraluminal Support Device, Open Approach, New Technology Group 9
• XNHG0F9 Insertion of Tibial Extension with Motion Sensors into Right Tibia, Open Approach, New Technology Group 9
• XNHH0F9 Insertion of Tibial Extension with Motion Sensors into Left Tibia, Open Approach, New Technology Group 9
• XNR80D9 Replacement of Skull with Ultrasound Penetrable Synthetic Substitute, Open Approach, New Technology Group 9
• XNRL099 Replacement of Right Tarsal with Talar Prosthesis Synthetic Substitute, Open Approach, New Technology Group 9
• XNRM099 Replacement of Left Tarsal with Talar Prosthesis Synthetic Substitute, Open Approach, New Technology Group 9
• XRGJ0B9 Fusion of Right Ankle Joint using Open-truss Design Internal Fixation Device, Open Approach, New Technology Group 9
• XRGK0B9 Fusion of Left Ankle Joint using Open-truss Design Internal Fixation Device, Open Approach, New Technology Group 9
• XRGL0B9 Fusion of Right Tarsal Joint using Open-truss Design Internal Fixation Device, Open Approach, New Technology Group 9
• XRGM0B9 Fusion of Left Tarsal Joint using Open-truss Design Internal Fixation Device, Open Approach, New Technology Group 9
• XW013L9 Introduction of Elranatamab Antineoplastic into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 9
• XW013S9 Introduction of Epcoritamab Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 9
• XW033K9 Introduction of Sulbactam-Durlobactam into Peripheral Vein, Percutaneous Approach, New Technology Group 9
• XW033P9 Introduction of Glofitamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 9
• XW033Q9 Introduction of Posoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 9
• XW033R9 Introduction of Rezafungin into Peripheral Vein, Percutaneous Approach, New Technology Group 9
• XW043K9 Introduction of Sulbactam-Durlobactam into Central Vein, Percutaneous Approach, New Technology Group 9
• XW043P9 Introduction of Glofitamab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 9
• XW043Q9 Introduction of Posoleucel into Central Vein, Percutaneous Approach, New Technology Group 9
• XW043R9 Introduction of Rezafungin into Central Vein, Percutaneous Approach, New Technology Group 9
• XW053T9 Introduction of Melphalan Hydrochloride Antineoplastic into Peripheral Artery, Percutaneous Approach, New Technology Group 9
• XW0DXJ9 Introduction of Quizartinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 9
• XW0DXN9 Introduction of SER-109 into Mouth and Pharynx, External Approach, New Technology Group 9
• XW133H9 Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9
• XW143H9 Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9
• XX20X89 Monitoring of Brain Electrical Activity, Computer-aided Detection and Notification, New Technology Group 9
• XX2F3W9 Monitoring of Musculoskeletal Muscle Compartment Pressure, Micro-Electro-Mechanical System, Percutaneous Approach, New Technology Group 9
• XXE2X19 Measurement of Cardiac Output, Computer-aided Assessment, New Technology Group 9
• XXE5XY9 Measurement of Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology, New Technology Group 9

Deleted codes (5)

• XV508A4 Destruction of Prostate using Robotic Waterjet Ablation, Via Natural or Artificial Opening Endoscopic, New Technology Group 4
• XW033G4 Introduction of Plazomicin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 4
• XW033H4 Introduction of Synthetic Human Angiotensin II into Peripheral Vein, Percutaneous Approach, New Technology Group 4
• XW043G4 Introduction of Plazomicin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 4
• XW043H4 Introduction of Synthetic Human Angiotensin II into Central Vein, Percutaneous Approach, New Technology Group 4

Revised titles (14)

• XRGA0R7 Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7 (was: Fusion of Thoracolumbar Vertebral Joint using Customizable Interbody Fusion Device, Open Approach, New Technology Group 7)
• XRGA3R7 Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7 (was: Fusion of Thoracolumbar Vertebral Joint using Customizable Interbody Fusion Device, Percutaneous Approach, New Technology Group 7)
• XRGA4R7 Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7 (was: Fusion of Thoracolumbar Vertebral Joint using Customizable Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7)
• XRGB0R7 Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7 (was: Fusion of Lumbar Vertebral Joint using Customizable Interbody Fusion Device, Open Approach, New Technology Group 7)
• XRGB3R7 Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7 (was: Fusion of Lumbar Vertebral Joint using Customizable Interbody Fusion Device, Percutaneous Approach, New Technology Group 7)
• XRGB4R7 Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7 (was: Fusion of Lumbar Vertebral Joint using Customizable Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7)
• XRGC0R7 Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7 (was: Fusion of 2 or more Lumbar Vertebral Joints using Customizable Interbody Fusion Device, Open Approach, New Technology Group 7)
• XRGC3R7 Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7 (was: Fusion of 2 or more Lumbar Vertebral Joints using Customizable Interbody Fusion Device, Percutaneous Approach, New Technology Group 7)
• XRGC4R7 Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7 (was: Fusion of 2 or more Lumbar Vertebral Joints using Customizable Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7)
• XRGD0R7 Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7 (was: Fusion of Lumbosacral Joint using Customizable Interbody Fusion Device, Open Approach, New Technology Group 7)
• XRGD3R7 Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7 (was: Fusion of Lumbosacral Joint using Customizable Interbody Fusion Device, Percutaneous Approach, New Technology Group 7)
• XRGD4R7 Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7 (was: Fusion of Lumbosacral Joint using Customizable Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7)
• XW00X27 Introduction of Anacaulase-bcdb into Skin, External Approach, New Technology Group 7 (was: Introduction of Bromelain-enriched Proteolytic Enzyme into Skin, External Approach, New Technology Group 7)
• XW01X27 Introduction of Anacaulase-bcdb into Subcutaneous Tissue, External Approach, New Technology Group 7 (was: Introduction of Bromelain-enriched Proteolytic Enzyme into Subcutaneous Tissue, External Approach, New Technology Group 7)